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Abstract: 
Acute stress-induced (Tako-tsubo) Cardiomyopathy is an increasingly recognised 
but insufficiently characterised syndrome. Here we investigate the pathophysiology 
of right ventricular (RV) involvement in Tako-tsubo and its recovery time-course. We 
prospectively recruited 31 Tako-tsubo patients with predominantly ST-elevation ECG 
and 18 controls of similar gender, age and comorbidity distribution. Patients 
underwent echocardiography and cardiac magnetic resonance (CMR) imaging on a 
3T Philips scanner in the acute phase (day 0-3 post presentation) and at 4 months 
follow-up. Visually, Echocardiography was able to identify only 52% of patients who 
showed RV wall motion abnormalities on CMR. Only CMR-derived RV EF (p=0.01) 
and Echocardiography-estimated Pulmonary artery Pressure (p=0.01) identify RV 
functional involvement in the acute phase. Although RV ejection fraction normalises 
in the majority of patients by 4 months, acutely there is RV myocardial edema in both 
functioning and malfunctioning segments, as measured by prolonged native T1 
mapping (p=0.02 for both vs controls) and this persists at 4 months in the acutely 
malfunctioning segments (p=0.002 vs controls). The extra-cellular volume fraction 
was significantly increased acutely in all RV segments and remained increased at 
follow up compared to controls (p=0.004 for all). In conclusion, in a Tako-tsubo 
population presenting predominantly with ST-elevation ECG, we demonstrate that 
although RV functional involvement is seen in only half of patients, RV myocardial 
edema is present acutely throughout the RV myocardium in all patients and results in 
microscopic fibrosis at 4 months follow-up. 
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Acute stress induced (Tako-tsubo) cardiomyopathy is an increasingly recognized 
clinical syndrome. Whilst classically viewed as an acute disorder of the left 
ventricular (LV) systolic function (often triggered by intense emotional of physical 
trauma), right ventricular (RV) involvement has been increasingly described 1,2,3,4,5.  
Although it is not uniformly clear if RV involvement portends a worse outcome, 
involvement of the RV has been associated with greater LV dysfunction, more 
frequent complications1,2,6 or prolonged hospital stay1,5,6,7. We have previously 
demonstrated that the initial LV dysfunction in Tako-tsubo is accompanied by a 
significant degree of LV myocardial oedema8,9 and profound LV energetic 
impairment8 with incomplete resolution of both after 4 months. Although RV 
dysfunction appears to characterise those with a worse spectrum of LV dysfunction, 
the nature of the pathophysiology underlying the RV involvement is unknown and the 
recovery time-course of the RV has not been described. In the current study we 
investigated in a prospectively recruited, predominantly ST-elevation Tako-tsubo 
population: 1) the prevalence and extent of RV functional involvement, 2) the RV 
myocardial tissue characteristics and 3) the recovery time-course of the RV at 4 
months follow-up.     
 
Methods: 
Thirty-one consecutive consenting patients (28 women,  median age 64 
years, (range 41-84 years) who met the Mayo Clinic criteria10 for Tako-tsubo were 
recruited from Aberdeen Royal Infirmary between 2013-2015. All patients were 
initially suspected of myocardial infarction and most were brought in by Scottish 
Ambulance Service via the primary percutaneous coronary intervention service. 
Patients were studied in the acute phase (day 0-3 after presentation) and re-studied 
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after 4 months. Eighteen controls of similar age (mean 63 years, range 47-80 years), 
gender (16 women) and comorbidity distribution were also recruited. The study was 
approved by the North of Scotland Research Ethics Committee and all subjects 
provided informed consent. 
 
Echocardiography was performed using a Vingmed E9 system (GE 
Healthcare, Norway) with a 2.5 MHz probe. Standard images were acquired from 
parasternal, apical and subcostal views. Tissue Doppler images of the RV (at lateral 
tricuspid annular level) were used to derive E’, A’ and S’ indices.  
 
A 3T Philips Achieva (Best, The Netherlands) was used for cardiac magnetic 
resonance (CMR) imaging. After localisers, 2,3 and 4-chamber views and a full short 
axis cine stack were acquired, as well as a full short axis stack of native and post-
contrast 3-3-5 Modified Look-Locker Imaging T1 mapping11.  
 
Both Echo and CMR images were each analysed by a pair of two 
independent expert observers (CS, AR, CN and JS) blinded to each other, to the 
other imaging modality and for T1 mapping to the order of the scan.  Qualitative 
interpretation (wall motion score) was resolved by adjudication/agreement with a 
third expert. All quantitative analyses were subjected to inter-observer variability. 
Echo images were analyzed offline using Echopac (GE Healthcare, Norway). 
Pulmonary artery pressure (PaP) was derived from the maximum tricuspid 
regurgitation velocity as measured by the formula 4v2+estimated right atrial pressure 
depending on the inferior vena cava collapse during inspiration. A simple index of RV 
longitudinal function was also measured as Tricuspid annular pan-systolic excursion 
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(TAPSE) as previously described12. The CMR images were analysed in CMR Tools 
(Cardiovascular Imaging Solutions, London, UK) for computation of LV volumes and 
mass, RV volumes and to derive volumetric Ejection Fractions for the two ventricles. 
RV Wall motion score index was obtained using a 6 segment model where the basal, 
mid-cavity and apical slices were each divided into anterior and posterior segments 
(Figure 1A). Each segment was scored for functional status (1=normal, 
2=hypokinetic, 3=akinetic, 4=dyskinetic). T1 maps were generated using Philips’ 
RelaxMap, quality controlled with chi-square maps and imported into Image J (NIH, 
USA)  where pre and post contrast T1 values for the RV myocardium were 
generated for each of the 6 segments13. To avoid the difficulties posed by the thin 
RV wall and possible partial volume effect, all T1 map images were co-registered 
with the exact spatially corresponding cine sequences in the following manner: the 
RV boundaries were carefully delineated manually on magnified cine images, then 
inwardly eroded by at least 2 pixels in order to avoid blood on the endocardial side or 
fat on the epicardial side and finally the ROI’s thus obtained were imported into the 
corresponding T1 map images for deriving pre and post-contrast T1 values. 
Extracellular volume fraction (ECV) was calculated according to the formula:  
 
A repeat Echocardiogram and CMR were scheduled at 4 months and 
achieved in 28 patients due to death (2) and device implant (1). 
 
Data are presented as mean±SD or median (range) if not normally distributed. 
Comparisons between controls and patients or between patients at baseline and 
follow-up were performed using independent/paired Students’ t test or Mann Whitney 
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rank-sum/Wilcoxon signed-rank tests depending on the data distribution. In order to 
account for multiple comparisons the p value chosen for statistical significance was 
Bonferroni-adjusted depending on the number of variables compared between 
groups. Inter-observer variabilities were calculated as mean±SD of the percentage 
ratios between differences and means of the 2 independently measured variables. 
 
Results 
General characteristics are shown in Table 1. In this study cohort most 
patients were middle-age and elderly women, with a preceding emotional trigger, 
presenting with ST-elevation ECG’s, modest Troponin rise and apical-type 
ballooning. The controls were chosen to be similar in age and gender distribution to 
the Tako-tsubo patients, and to have a comparable cardiac past medical 
history/therapy. Typically, Tako-tsubo patients were given the emergency therapy 
required for a presumed myocardial infarction until the diagnosis of Tako-tsubo was 
established at cardiac catheterisation; after this, medication was re-established as 
before presentation in each case.  
 
RV systolic wall motion was assessed on a segmental basis as presented in 
Figure 1A. Tako-tsubo patients were grouped according to the wall motion score 
index (WMSI) on CMR images as those with RV involvement (RV+, mean WMSI 
1.5±0.3, n=16) and without RV involvement (RV-, WMSI=1, n=15). There was no 
difference between the RV+ and RV- groups with regard to age, past medical history, 
heart rate or systolic/diastolic blood pressure at presentation (p=ns for all). Figure 
1B shows a typical example of RV dyskinesia.  In all cases, only the apical and mid-
cavity RV segments were seen to be involved. Of note, Echocardiography was able 
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to identify a wall motion abnormality in only 9 patients in the RV+ group (52%). Table 
2 shows that in both groups there was a significant improvement in LV EF at 4 
months compared to baseline (p<0.01 in both). The RV+ group had decreased RV 
EF (p=0.01), decreased TAPSE (p=0.002) and increased PaP (p=0.01) acutely 
compared to follow-up and also compared to controls (all p<0.01). The RV- group 
also showed a decreased TAPSE acutely compared to controls (p=0.002), which 
improved at follow up (p=0.001 vs acute). 
On T1 mapping assessment, individual RV segments from Tako-tsubo 
patients were grouped according to their WMS during acute presentation and 
compared to those of the control group. Table 3 shows that native T1 was 
significantly prolonged during acute presentation in segments with abnormal wall 
motion and also in segments with normal wall motion (p=0.02 for both), suggesting 
that acutely there is a degree of myocardial edema present throughout the RV. The 
segments showing wall motion abnormalities during the acute phase continued to 
have a significantly prolonged precontrast T1 even at 4 months follow-up (p=0.002 
compared to controls). Similarly, the post-contrast T1 values were significantly 
shorter at acute presentation study compared to controls, irrespective of their wall 
motion (p=0.004 for both). The ECV was significantly increased acutely in all RV 
segments and remained increased at follow up compared to controls (p=0.002 for 
all). An example is shown in Figure 2. 
The average inter-observer variabilities for Echo, CMR and T1 mapping 
measurements were: 4±2%, 3±1% and 5±3% respectively. 
Discussion: Firstly, we demonstrate that CMR is superior to standard 
Echocardiography in detecting RV functional involvement in acute Tako-tsubo. This 
is not surprising since CMR is the accepted gold standard for RV assessment and 
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thus it is possible that previous studies may have underestimated the extent of RV 
involvement in this condition. A reduced RV EF and increased PaP characterise the 
RV+ group, in keeping with previous observations3,4,5. Interestingly, in our study, the 
group designated RV- by visual assessment of wall motion also showed a modest 
but significantly reduced TAPSE acutely, which improved at follow-up, suggesting 
discrete abnormalities in the long axis function of the RV even in this group. A 
previous report showed that RV global longitudinal strain was able to distinguishing 
RV involvement on Echocardiography, whereas TAPSE was not4. It is possible that 
our patient cohort who presented predominantly as ST-elevation ECG’s were 
diagnosed and scanned at an earlier stage. Additionally, while our findings may 
characterize a most severe spectrum of Tako-tsubo disease, they cannot be 
extrapolated to the less severe clinical presentations.  
Secondly, a significant finding of this study is that of myocardial edema, 
involving the RV and present beyond the boundaries of the dysfunctional 
myocardium during the acute phase, similar to the LV pattern of involvement that we 
recently described14. Taken together, these findings are the first evidence to suggest 
that Tako-tsubo is a condition that affects the whole ventricular myocardium. This 
supports the concept that Tako-tsubo is a more systemic condition than previously 
thought, with a provoking stimulus that is capable to affect the entire left and right 
ventricular myocardium. Despite these striking findings of pan-myocardial edema, 
Tako-tsubo shows specific localization of functional involvement in both the RV and 
LV myocardium, since often the apex and part of the mid-cavity myocardium is 
dyskinetic whereas the base of the heart is hyperkinetic. Previous authors have 
already suggested that an explanation for the differential functional responses of 
myocardial territories may lie in the distribution and relative proportions of the beta-
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adrenergic receptors within the LV myocardium15, although this has never been 
investigated in the human RV. We further demonstrate that RV myocardial edema 
also shows incomplete resolution at 4 months follow-up, persisting in the segments 
which showed impaired contractility during the acute phase.  
Another important observation is that RV involvement does not appear to 
have any systemic haemodynamic consequences in those with clear RV wall motion 
abnormalities in the acute phase, as there were no differences in systemic blood 
pressure or heart rate between groups. This observation suggests that factors other 
than hemodynamic status may dictate a worse clinical course for those who manifest 
functional RV involvement. Taken together, our data show that not only the 
pathophysiology of Tako-tsubo is distinctively different form that of acute coronary 
syndromes, but also that the clinical markers for identifying patients at high risk may 
also be different. These findings also support a primary myocardial inflammatory 
hypothesis as a response to stress. Further research is needed to define the type of 
inflammation associated with Tako-tsubo and this may pave the way to suitable 
therapies. 
Thirdly, we show that the RV myocardium continues to have an increased 
ECV at 4 months in all segments, irrespective of their functional involvement during 
the acute phase. This suggests that a degree of microscopic myocardial fibrosis 
develops in the RV of these patients, as previously shown in myocardial biopsies 
from the LV by other authors16. This is also in keeping with clinical reports of Tako-
tsubo patients remaining symptomatic in longer term and builds further to the 
growing body of evidence that an episode of acute Tako-tsubo leaves a signature in 
the myocardium.  
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In keeping with observations already made at 1.5T magnetic field17, the T1 
values we measured in the RV in our study at 3T are indeed different from those 
measured in the LV8, due to the different proportions of myocytes and collagen found 
even in the normal RV. Even though we report RV T1 mapping values at 3T for the 
first time, it is unlikely that the higher pre-contrast and lower post-contrast T1 values 
in the RV are a reflection of the patients’ comorbidities (in general Tako-tsubo 
patients are “healthier” compared to coronary artery disease patients) – and our 
control population was well matched to avoid this confounder. Finally, the current 
study is proof of concept work and thus it enrolled a small number of patients, 
therefore these findings will need confirmation in future larger studies. 
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 FIGURE LEGENDS: 
Figure 1: A - Schematic representation of the RV segmentation for wall motion 
score interpretation; the segmental WMS were: 1.7, 1.4, 1.4, 1.3, 1, 1 for 
segments 1,2,3,4,5 and 6 respectively. 
Figure 1: B – Typical End-diastolic (ED) and End-systolic (ES) frames 
demonstrating LV and RV (arrows) apical ballooning, large pleural effusions 
are also seen. 
Figure 2: Pre and post contrast T1 maps in a control (a,b) and an ASC patient 
with functional RV involvement (c,d) demonstrating normal RV versus RV wall 
edema during the acute scan (hues of orange vs hues of yellow-green) and 
normal RV versus microscopic fibrosis at follow-up scan (hues of blue vs hues 
of yellow-green). The respective numeric mapping scales are shown on the 
right. 
 
 
 
 
 
 
        
 
 
 
 
 
   
 
Table 1. Clinical characteristics of the Tako-tsubo patients and controls 
 
Clinical Characteristics Tako-tsubo  
(n=31) 
Controls 
(n=18) 
Past medical history   
     Hypertension  7 (22%) 4 (22%) 
     Prior coronary artery disease 1 (3%) - 
     Diabetes mellitus  2 (6%) - 
     Thyroid disease  8 (26%) 5 (27%) 
     Mental health disorder  9 (29%) - 
     Previous Tako-tsubo  6 (19%) - 
     Smoker  11 (35%) 6 (33%) 
     Alcohol abuser 3 (9%) - 
     Body mass index>25 kg/m2 16 (51%) 9 (50%) 
Clinical presentation   
     Chest pain  25 (81%)  
     Syncope/pre-syncope 4 (13%)  
     Ventricular tachycardia  2 (6%)  
Precipitating emotional stressor 
No stressor 
27 (87%) 
4(13%) 
 
Heart rate at presentation [bpm, 
mean±SD] 
80±14  
Systolic blood pressure at presentation 
[mm Hg, mean±SD] 
125±23  
Diastolic blood pressure at presentation 
[mm Hg, mean±SD] 
79±17  
ECG changes at presentation   
     ST-elevation 25 (81%)  
     T wave inversion 4 (12%)  
     LBBB 2 (7%)  
Troponin I (ng/ml)   
     At presentation [median, (range)] 1.28 (<0.04, 10.93)  
     12 hour [median, (range)] 3.45 (0.22, 11.97)  
Table 1
   
 
C-reactive protein [median, (range)] 21.5 (<4, 75)  
Coronary disease at angiography   
     Left anterior descending <50% 6 (19%)  
     Left circumflex <50% 1 (3%)  
     Right coronary artery <50% 6 (19%)  
Left ventricular angiogram   
     Apical ballooning 26 (84%)  
     Mid-cavity ballooning 5 (16%)  
Drug history   
     Aspirin 3 (9%) - 
     Beta-blocker 1 (3%) - 
     ACE inhibitor 6 (19%) 2 (11%) 
     Calcium channel blocker 3 (9%) - 
     Statin  4 (12%) - 
     Diuretic  5 (16%) 3 (16%) 
 
Data are shown as n (%) unless otherwise stated. 
 
 
   
 
Table 2. Imaging Characteristics of Tako-tsubo patients with and without Right ventricular 
involvement (RV+/-) and healthy controls 
        Controls                                       Acute study (day 0-3)      Follow up (4 months) 
  
n=18 
           RV+ 
          n=16 
RV- 
n=15 
RV+ 
n=14 
RV- 
n=14 
         Cardiac Magnetic Resonance     
Left ventricular end-diastolic volume (ml) 133±14 126±35 131±22 122±21 127±16 
Left ventricular end-diastolic volume index (ml/m2) 73±6 80±20 74±13 78±12 71±10 
Left ventricular end-systolic volume (ml) 45±8 67±30† 57±20† 45±15 45±11 
Left ventricular end-systolic volume index (ml/m2) 24±4 42±18† 32±12† 28±9 25±7 
Left ventricular mass (g) 121±13 137±16† 134±18† 125±17 118±18 
Left ventricular mass index (g/m2) 66±10 84±10† 77±17† 75±11 70±14 
Left ventricular ejection fraction (%) 67±4 48±10† 60±8† 63±6 64±6 
Right ventricular end-diastolic volume (ml) 100±20 121±23 107±22 111±20 107±26 
Right ventricular end-diastolic volume index (ml/m2) 58±9 66±12 58±10 60±10 58±13 
Right ventricular end-systolic volume (ml) 44±7 43±15 38±7 38±15 34±9 
Table 2
   
 
Right ventricular end-systolic volume index (ml/m2) 25±4 25±10 20±4 22±10 18±4 
Right ventricular ejection fraction (%) 63±5 57±11† 63±9 66±11 67±8 
          Echocardiography     
Right ventricular E’ (cm/s) 0.14±0.01 0.09±0.04 0.10±0.04 0.12±0.02 0.11±0.03 
Right ventricular A’ (cm/s) 0.16±0.01 0.17±0.05 0.14±0.05 0.13±0.05 0.15±0.04 
Right ventricular S’ (cm/s) 0.13±0.01 0.09±0.02 0.12±0.03 0.12±0.03 0.12±0.03 
Tricuspid annular pan-systolic excursion (cm) 2.6±0.1 1.7±0.4† 2.0±0.3† 2.4±0.5 2.6±0.4 
Pulmonary artery Pressure - estimated (mm Hg) 24±7 43±15† 31±6 33±8 29±6 
 
All data shown as mean±SD. 
 p0.01 acute study vs follow-up (paired t-test) 
† p0.01 acute study vs controls 
 
 
 
 
   
 
 
 
 
 
 
   
 
  Table 3: Native and post-contrast Right Ventricular T1 mapping values and extracellular volume fraction from segments with 
normal or abnormal wall motion from Tako-tsubo patients compared to all segments form controls. Native T1 
mapping is indicative of edema whereas extracellular volume fraction is indicative of microscopic myocardial 
fibrosis. 
 
 Controls Acute study (day 0-3) Follow up (4 months) 
Native Right Ventricular T1 mapping - normal wall motion (ms) 1310±92 1399±88 1356±58 
Native Right Ventricular T1 mapping - abnormal wall motion (ms) - 1459±128 1478±88 
Post-contrast Right Ventricular T1 mapping - normal wall motion (ms) 523±42 484±40 501±42 
Post-contrast Right Ventricular T1 mapping abnormal wall motion (ms) - 456±17 478±47 
Right ventricular Extracellular volume fraction normal wall motion (%) 0.33±0.03 0.40±0.04 0.41±0.05 
Right ventricular Extracellular volume fraction abnormal wall motion (%) - 0.42±0.04 0.42±0.05 
 
 p<0.03 acute or follow-up study vs healthy control myocardium 
 
 
Table 3
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